Virginia is attracting billions in broad-scale biopharma investments toward its established life sciences footprint. Leaders across business, government and academia see an opportunity to build on that momentum and strengthen the partnerships and workforce supporting the industry’s next phase.
Join Axios Live in Richmond for an event on Virginia’s growing biotech sector. We’ll discuss policy’s role in expanding U.S. manufacturing, building a skilled workforce through training and education, and the public-private partnerships that could sustain investment and long-term growth across the Commonwealth.
Subscribe to Axios Richmond:Â Get smarter, faster with a daily look at the biggest stories in Richmond
